Wolverine Asset Management LLC Invests $2.20 Million in Abrdn Healthcare Investors (NYSE:HQH)

Wolverine Asset Management LLC acquired a new stake in shares of Abrdn Healthcare Investors (NYSE:HQH) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 136,831 shares of the financial services provider’s stock, valued at approximately $2,196,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQH. Truvestments Capital LLC bought a new position in Abrdn Healthcare Investors during the 3rd quarter valued at $46,000. FNY Investment Advisers LLC acquired a new stake in shares of Abrdn Healthcare Investors in the fourth quarter valued at $48,000. TD Private Client Wealth LLC bought a new position in Abrdn Healthcare Investors during the third quarter valued at about $66,000. Stratos Wealth Partners LTD. acquired a new position in Abrdn Healthcare Investors during the fourth quarter worth about $187,000. Finally, Stifel Financial Corp bought a new stake in Abrdn Healthcare Investors in the third quarter worth about $188,000. Institutional investors own 32.60% of the company’s stock.

Abrdn Healthcare Investors Price Performance

Shares of NYSE HQH opened at $17.63 on Friday. Abrdn Healthcare Investors has a twelve month low of $15.76 and a twelve month high of $19.79. The firm has a 50-day moving average of $17.15 and a two-hundred day moving average of $17.96.

Abrdn Healthcare Investors Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, February 21st will be paid a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 12.93%. The ex-dividend date of this dividend is Friday, February 21st.

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.